The future of live sport lies in your living room
Read More
Forbes talks to Jonathan Ross, the CEO and founder of Groq
Read More
Owkin announced that two first-in-class rapid, affordable AI-based diagnostic solutions – designed to improve outcomes for patients with breast cancer and colorectal cancer – approved for use in Europe
Read More
An EU-funded project has shown its potential to transform the pharma industry, according to Owkin
Read More
Advances converged HPC and ML solutions with Groq's proprietary compute architecture and Maxeler's rich systems portfolio
Read More